Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue [EXTENSION OF 700012063]
Phase of Trial: Phase III
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia; Prostate cancer
- Focus Pharmacodynamics
- 17 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 17 Apr 2019 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
- 17 Apr 2019 Status changed from active, no longer recruiting to suspended.